Uafhængigt af baseline- karakteristika viste de fleste patienter histologisk og virologisk respons på behandling.
38 both associated with higher rates of virologic response (Week 48 HBV DNA < 400 copies/ ml) in nucleoside-naive HBeAg-positive patients.